Cargando…

Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact

OBJECTIVE: Analyze the cost contributors and their impact on the drug cost avoidance (DCA) resulting from cancer clinical trials over the period of 2015–2020 in a tertiary-level hospital in Spain (HCUVA). METHODS: We performed a cross-sectional, observational, retrospective study of a total of 53 cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez Martínez, Domingo Antonio, Salas-Lucia, Federico, Jiang, Hanzi, Ruiz-Carreño, Paula, Alonso Romero, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316356/ https://www.ncbi.nlm.nih.gov/pubmed/35883128 http://dx.doi.org/10.1186/s12913-022-08222-9

Ejemplares similares

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability
por: Casado, Virginia, et al.
Publicado: (2006)

Cost of Disorders of the Brain in Spain
por: Parés-Badell, Oleguer, et al.
Publicado: (2014)

Cost of early-stage mycosis fungoides treatments in Spain
por: Ortiz-Romero, Pablo Luis, et al.
Publicado: (2020)

Achieving Value in Spine Surgery: 10 Major Cost Contributors
por: Philipp, Lucas R., et al.
Publicado: (2021)

Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021)

A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application
por: García-Sánchez, Sebastián, et al.
Publicado: (2022)

Costs and healthcare utilisation of patients with heart failure in Spain
por: Escobar, Carlos, et al.
Publicado: (2020)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain
por: Zozaya, Néboa, et al.
Publicado: (2021)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

The global cost of eliminating avoidable blindness
por: Armstrong, Kirsten L, et al.
Publicado: (2012)

Hidden costs of HIV treatment in Spain: inefficiency of the antiretroviral drug packaging
por: Llibre-Codina, Josep M, et al.
Publicado: (2014)

Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
por: Olry de Labry Lima, Antonio, et al.
Publicado: (2021)

Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2017)

Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study
por: Bouzón-Alejandro, Marta, et al.
Publicado: (2011)

The cost of living: an avoidable public health crisis
por: The Lancet Public Health
Publicado: (2022)

Cost-effectiveness analysis of timely dialysis referral after renal transplant failure in Spain
por: Villa, Guillermo, et al.
Publicado: (2012)

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
por: Alsina, Laia, et al.
Publicado: (2021)

How much does a forensic autopsy cost in Spain?
por: Martín-Cazorla, Fernando, et al.
Publicado: (2022)

Avoiding Costly Conservation Mistakes: The Importance of Defining Actions and Costs in Spatial Priority Setting
por: Carwardine, Josie, et al.
Publicado: (2008)

Costs, outcomes and challenges for diabetes care in Spain
por: Lopez-Bastida, Julio, et al.
Publicado: (2013)

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
por: Majem, Margarita, et al.
Publicado: (2022)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
por: Colet, Josep Comín, et al.
Publicado: (2023)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022)

Costs and healthcare utilisation of patients with chronic kidney disease in Spain
por: Escobar, Carlos, et al.
Publicado: (2021)

Comments on “Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain”
por: Gómez, David Gómez
Publicado: (2021)

Cost of postoperative complications: How to avoid calculation errors
por: De la Plaza Llamas, Roberto, et al.
Publicado: (2020)

Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption
por: Gavurova, Beata, et al.
Publicado: (2021)

Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain
por: Olry de Labry Lima, Antonio, et al.
Publicado: (2021)

On Measurement of Avoidable and Unavoidable Cost of Alcohol: An Application of Method for Estimating Costs Due To Prior Consumption
por: Jarl, Johan, et al.
Publicado: (2010)

Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain
por: Gómez-Casares, María Teresa, et al.
Publicado: (2017)

Drug costs in context: assessing drug costs in cost-of-illness analyses
por: Mattingly, T Joseph, et al.
Publicado: (2022)

Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study
por: Trapero-Bertran, Marta, et al.
Publicado: (2017)

Impact of immigration on the cost of emergency visits in Barcelona (Spain)
por: Cots, Francesc, et al.
Publicado: (2007)

Long-term costs of colorectal cancer treatment in Spain
por: Corral, Julieta, et al.
Publicado: (2016)

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
por: Darbà, Josep, et al.
Publicado: (2015)

Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain
por: García, Amos, et al.
Publicado: (2016)

Counting the cost of COVID-19 at the peak of the pandemic in Spain
Publicado: (2021)

Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain
por: Álvarez-del Río, Blanca, et al.
Publicado: (2023)

Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study
por: Khair, Shahreen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3p61h956o997taorp28sfp8k2o